Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-04-05
2008-12-16
Kim, Jennifer Myong (Department: 1617)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
active
07465729
ABSTRACT:
The invention relates to the use of eszopiclone for the treatment of symptoms accompanying perimenopause or menopause.
REFERENCES:
patent: 5786357 (1998-07-01), Young et al.
patent: 6153216 (2000-11-01), Cordes et al.
patent: WO 93/10787 (1993-06-01), None
Soares et al. Six-month efficacy study of eszopiclone in perimenopausal and postmenopausal women with chronic insomnia. Obstetrics and Gynecology, Apr. 1, 2004, vol. 103, Suppl. No. 4 p. 102.
Furukawa et al., “Antidepressant and benzodiazepine for major depression,” John Wiley & Sons, Ltd., (1), 1-43, (2005).
Cohen, et al.; “Sleep in chronic pain: problems and treatments,” Int'l Review of Psychiatry; vol. 12, No. 2: pp.115-126 (2000).
Drewes et al.; “Zopiclione as Night Medication in Rheumatoid Arthritis,” Scand J Rheumatol; 27: 180-7 (1998).
Affleck G, Urrows S, Tennen H, Higgins P, Abeles M,Seqeuntial daily relations of sleep, pain intensity, and attention to pain among women with fibromyalgia pain68:363-368 (1996).
Asnis GM, Chakrabarty A, DuBoff EA, et al;Zolpidem for persistent insomnia in SSRI-treated depressed patientsJ Clin Psychiastry 60:668-676 (1999).
Barone P, Amboni M., Vitale C, Bonavita V.,Treatment of nocturnal disturbance and excessive daytime sleepiness in Parkinson's disease, Neurology 63:S35-S38 (2004).
Benca RM, Ancoli-Israel A, Moldofsky H.,Special considerations in insomnia diagnosis and management: Depressed, elderly, and chronic pain populationsJ Clin Psychiatry 65 (Suppl 8):26-35 (2004).
Billiard M, Bentley A.Is insomnia best categorized as a symptom or a disease? Sleep Medicine 5(Suppl 1):S35-S40 (2004).
Bliwise DL,Sleep disorders in Alzheimer's disease and other dementias, Clin. Cornerstone 6 Suppl 1A:S16-28 (2004).
Bloom BJ, Owens JA, McGuinn M, Nobile C., Shaeffer L, Alario AJ,Sleep and its relationship to pain, dysfunction, and disease activity in juvenile rheumatoid arthritis; J Rheumatol 29:169-173 (2002).
Bourguignon C, Labyak SE, Taibi D,Investigating sleep disturbances in adults with rheumatoid arthritis, Holist Nurs Pract 17:241-249 (2003).
Breslau N, Roth T, Rosenthal L, Andreski P,Sleep disturbance and psychiatric disorders: a longitudinal epidemiological study of young adults, Biol Psychiatry 39:411-418 (1996).
Chang PP, Ford DE, Mead LA et al.,Insomnia in young men and subsequent depression. The Johns Hopkins Precursors Study, Am J Epidemiol. 146:105-114 (1997).
Dorsey CM, Lee KA, Scharf MBEffect of zolpidem on sleep in women with perimenopausal and postmenopausal insomnia: A 4-week, randomized, multicenter, double-blind placebo-controlled studyClin Ther 16:873-897 (2004).
Drewes AMPain and sleep disturbances with special reference to fibromyalgia and rheumatoid arthritis, Rheumatology (Oxford) 38:1035-1038 (1999).
Drewes AM, Nielsen KD, Hansen B, Taagholt SJ, Bjerregard K, Svendsen L,A longitudinal study of clinical symptoms and sleep parameters in rheumatoid arthritis, Rheumatology (Oxford) 39:1287-1289 (2000).
Drewes AM, Svendsen L, Taagholt, Bjerregard k, Nielsen KD, Hansen B,Sleep in rheumatoid arthritis: a comparison with healthy subjects and studies of sleep/wake interactions, Br J Rheumatol 37:71-81 (1998).
Ford DE, Kamerow DB,Epidemiologic study of sleep disturbances and psychiatric disorders. An opportunity for prevention?, JAMA 262:1479-1484 (1989).
Ford DE, Cooper-Patrick L,Sleep disturbances and modd disorders:an epidemiologic perspective, Depress Anxiety 14:3-6 (2001).
Gillin JC,Are sleep disturbances risk factors for anxiety, depressive and addictive disorders? Acta Psychiatr Scand Suppl. 393:39-43 (1998).
Hyyppa MT, Kronholm E,Quality of sleep and chronic illnessesJ Clin Epidemiol 42:633-638 (1989).
Katz DA, McHorney CA.Clinical correlates of insomnia in patients with chronic illness.Arch Intern Med 158:1099-1107 (1998).
Koren D, Arnon I, Lavie P, et al.Sleep complaints as early predictors of posttraumatic stress disorder: a 1-year prospective study of injured survivors of motor vehicle accidents. Am J Psychiatry 159:855-857 (2002).
Livingston G, Blizard B, Mann A,Does sleep disturbance predict depression in elderly people? A study in inner London, Br J Gen Pract. 43:445-448 (1993).
Londborg PD, Smith WT, Glaudin V, Painter JR.Short-term cotherapy with clonazepam and fluoxetine: anxiety, sleep disturbance and core symptoms of depression., J. Affect Disord. 61:73-79 (2000).
Mahowald MW, Mahowald ML, Bundlie SR, Ytterberg SR,Sleep fragmentation in rheumatoid arthritisArthritis Rheum 32:974-983 (1989).
McCall MV,A psychiatric perspective on insomnia, J Clin Psychiatry 62(Suppl 10):27-32 (2001).
McCurry SM, Ancoli-Israel S,Sleep dysfunction in Alzheimer's disease and other dementiasCurr Treat Options Neurol 5:261-272 (2003).
Nierenberg AA, Keefe BR, Leslie VC et al,Residual symptoms in depressed patients who respond acutely to fluoxetineJ Clin Psychiatry 60:221-225 (1999).
Nolen, WA,Hypnotics as concurrent medication in depressionJrnl of Affective Disorders 28 (1993) 179-188.
O'Bryant SE, Palav A, McCaffrey RJ,A review of symptoms commonly associated with menopause: implications for clinical neuropsychologists and other health care providers, Neuropsychol Rev. 13:145-152 (2003).
Perlis ML, Giles DE, Buysse DJ, et al.Self-reported sleep disturbance as a prodromal symptom in recurrent depression. J Affect Disord 42:209-212 (1997).
Punjabi NM, Shahar E, Redline S, et al, Investigators SHHS,Sleep-disordered breathing, glucose intolerance, and insulin resistance: the Sleep Heart Health StudyAm J Epidemiol 160:521-530 (2004).
Renko, A, Hiltunen L, Laakso M, et al.The relationship of glucose tolerance to sleep disorders and daytime sleepinessDiabetes Res Clin Pract 67:84-91 (2005).
Rickels K, Schweizer E, Case WG, DeMartinis N, Greenblatt DJ, Mandos LA, Espana FG.Nefazodone in major depression: adjunctive benzodiazepine therapy and tolerability, J, Clin Psychopharmacol 18:145-153 (1998).
Riemann D, Voderholzer U,Primary Insomnia: a risk factor to develop depression, J Affect Disord 76:255-259 (2003).
Shaver JL,Women and sleep, Nurse Clin North Am. 37:707-718 (2002).
Smith WT, Londborg PD, Glaudin V, Painter JR.Shortterm augmentation of fluoxetine with clonazepam in the treatment of depression: a doub-blind study, Am J. Psychiatry 155:1339-1345 (1998).
Smith WT, Londborg PD, Glaudin V, Painter JR. Summit Research Network.Is extended clonazepam cotherapy of fluoxetine effective for outpatients with major depression?, J Affect Disord 70:251-259 (2002).
Thorpy MJ,Sleep disorders in Parkinson's diseaseClin Cornerstone 6 Suppl 1A:S7-15 (2004).
Tishler M, Barak Y, Paran D, Yaron M.,Sleep disturbances, fibromyalgia and primary Sjogren's syndromeClin Exp Rheumatol 15:71-74 (1997).
Van Cauter E, Polonsky KS, Scheen AJ,Roles of circadian rhythmicity and sleep in human glucose regulationEndocr Rev 18:716-738 (1997).
Walsh JK,Clinical and socioeconomic correlates of insomnia; J Clin Psychiatry 65 (Suppl 8):13-19 (2004).
Zamir G, Press J, Tal A, Tarasiuk A,Sleep fragmentation in children with juvenile rheumatoid arthritisJ Rheumatol 25:1191-1197 (1998).
Caron Judy
Wessel Thomas
Heslin Rothenberg Farley & & Mesiti P.C.
Kim Jennifer Myong
Sepracor Inc.
LandOfFree
Methods of treatment of menopause and perimenopause using... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of treatment of menopause and perimenopause using..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of treatment of menopause and perimenopause using... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4038568